These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 32428014

  • 21. Relationship between inappropriate left ventricular hypertrophy and ejection fraction independent of absolute or indexed mass in a community sample of black African ancestry.
    Libhaber CD, Norton GR, Maseko MJ, Majane OH, Millen AM, Maunganidze F, Michel FS, Brooksbank R, Libhaber E, Sareli P, Woodiwiss AJ.
    J Hypertens; 2013 Jan; 31(1):169-76. PubMed ID: 23095760
    [Abstract] [Full Text] [Related]

  • 22. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
    Kim JY, Lee Y, Kang HG, Ha IS, Cheong HI, Choi HJ, Han KH, Kim SH, Cho MH, Shin JI, Lee JH, Park YS, Cho H.
    BMC Nephrol; 2020 Dec 09; 21(1):533. PubMed ID: 33297989
    [Abstract] [Full Text] [Related]

  • 23. The association of echocardiographic parameters on renal outcomes in chronic kidney disease.
    Huang TH, Chiu H, Wu PY, Huang JC, Lin MY, Chen SC, Chang JM.
    Ren Fail; 2021 Dec 09; 43(1):433-444. PubMed ID: 33682579
    [Abstract] [Full Text] [Related]

  • 24. The Prevalence of Left Ventricular Hypertrophy in Obese Children Varies Depending on the Method Utilized to Determine Left Ventricular Mass.
    Mahgerefteh J, Linder J, Silver EJ, Hazin P, Ceresnak S, Hsu D, Lopez L.
    Pediatr Cardiol; 2016 Aug 09; 37(6):993-1002. PubMed ID: 27033247
    [Abstract] [Full Text] [Related]

  • 25. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G.
    J Hypertens; 2009 Dec 09; 27(12):2465-71. PubMed ID: 19898252
    [Abstract] [Full Text] [Related]

  • 26. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 27. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
    Brady TM, Roem J, Cox C, Schneider MF, Wilson AC, Furth SL, Warady BA, Mitsnefes M.
    Am J Kidney Dis; 2020 Aug 05; 76(2):166-173. PubMed ID: 32389356
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Indexing left ventricular wall thickness to body surface area improves prognostic value.
    LaBounty TM, Bach DS, Bossone E, Kolias TJ.
    Echocardiography; 2019 May 05; 36(5):824-830. PubMed ID: 30905085
    [Abstract] [Full Text] [Related]

  • 31. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults.
    Zalawadiya SK, Gunasekaran PC, Bavishi CP, Veeranna V, Panaich S, Afonso L.
    Eur J Prev Cardiol; 2015 May 05; 22(5):673-9. PubMed ID: 24699336
    [Abstract] [Full Text] [Related]

  • 32. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M, Korzeniowska B, Tendera M.
    Int J Cardiol; 2006 Jan 26; 106(3):382-9. PubMed ID: 15996771
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass.
    Hernández D, González A, Rufino M, Laynez I, de la Rosa A, Porrini E, Lacalzada J, Barragán A, Lorenzo V, Torres A.
    Nephrol Dial Transplant; 2007 Sep 26; 22(9):2678-85. PubMed ID: 17510095
    [Abstract] [Full Text] [Related]

  • 35. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
    Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT, HALT PKD Study Group, Meyers CM.
    Clin J Am Soc Nephrol; 2011 Oct 26; 6(10):2508-15. PubMed ID: 21903983
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, Roussos D, Andreou I, Tsantilas A, Christoforatou E, Pitsavos C, Panagiotakos D, Stefanadis C.
    J Hypertens; 2011 Aug 26; 29(8):1624-32. PubMed ID: 21610511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.